Comparative effectiveness of pegcetacoplan versus ravulizumab in patients with paroxysmal nocturnal hemoglobinuria previously treated with eculizumab: a matching-adjusted indirect comparison
Author:
Affiliation:
1. Analysis Group, Inc, Boston, MA, USA
2. Apellis Pharmaceuticals, Inc, Waltham, MA, USA
Funder
Apellis Pharmaceuticals, Inc
Apellis Pharmaceuticals, Inc.
Publisher
Informa UK Limited
Subject
General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/03007995.2021.1971182
Reference33 articles.
1. Stem cell transplantation for paroxysmal nocturnal hemoglobinuria
2. Epidemiology of PNH and Real-World Treatment Patterns Following an Incident PNH Diagnosis in the US
3. Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria
4. Sustained response and long-term safety of eculizumab in paroxysmal nocturnal hemoglobinuria
5. Long-term effect of the complement inhibitor eculizumab on kidney function in patients with paroxysmal nocturnal hemoglobinuria
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Exploring treatment strategies for paroxysmal nocturnal hemoglobinuria: an overview of registered clinical trials;Current Medical Research and Opinion;2024-05-16
2. Cost-Utility Analysis Comparing Pegcetacoplan to Anti-C5 Monoclonal Antibodies in the Treatment of Paroxysmal Nocturnal Hemoglobinuria;ClinicoEconomics and Outcomes Research;2024-04
3. Efficacy and safety of current treatments for paroxysmal nocturnal hemoglobinuria: A systematic review;Clinical Immunology Communications;2023-12
4. Paroxysmal nocturnal hemoglobinuria: Review of the patient experience and treatment landscape;Blood Reviews;2023-11
5. A methodological review of population-adjusted indirect comparisons reveals inconsistent reporting and suggests publication bias;Journal of Clinical Epidemiology;2023-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3